>Q9NZJ5_Disorder
83-98, 124-142, 250-257, 357-363, 438-446, 566-581, 679-694, 727-742, 768-788, 809-823, 842-865, 1097-1116
meraispgll vralllllll lglaartvaa grarglpapt aeaafglgaa aaptsatrvp aagavaaaev tvedaealpa aaGEQEPRGP EPDDETELrp rgrslviist ldgriaaldp enhGKKQWDL DVGSGSLVSS SLskpevfgn kmiipsldga lfqwdqdres metvpftves llessykfgd dvvlvggksl ttyglsaysg kvryicsalg crqwdsdeme qeedilllqr tqktvravgP RSGNEKWnfs vghfelryip dmetragfie stfkpnente eskiisdvee qeaaimdivi kvsvadwkvm afskkgghle weyqfctpia sawllkdgkv ipislfDDTS YTSnddvled eediveaarg atensvylgm yrgqlylqss vrisekfpss pkalesvtne naiiplptik wkplihsPSR TPVLVGsdef dkclsndkfs heeysngals ilqypydngy ylpyykrern krstqitvrf ldnphynkni rkkdpvlllh wwkeivatil fciiattfiv rrlfhphphr qrkesetqcq tenkyDSVSG EANDSSWNDI Knsgyisryl tdfepiqclg rggfgvvfea knkvddcnya ikrirlpnre larekvmrev kalaklehpg ivryfnawle appekwqekm deiwlkdeST DWPLSSPSPM DAPSvkirrm dpfatkehie iiapspqrsr sfsvgiSCDQ TSSSESQFSP LEfsgmdhed isesvdaayn lqdscltDCD VEDGTMDGND EGHSFELCps easpyvrsre rtsssivfED SGCDNASSKE EPKtnrlhig nhcankltaf kPTSSKSSSE ATLSISPPRP TTLSLdltkn tteklqpssp kvylyiqmql crkenlkdwm ngrctieere rsvclhiflq iaeaveflhs kglmhrdlkp snifftmddv vkvgdfglvt amdqdeeeqt vltpmpayar htgqvgtkly mspeqihgns yshkvdifsl glilfellyp fstqmervrt ltdvrnlkfp plftqkypce yvmvqdmlsp spmerpeain iienavfedl dfpgktvlrq rsrslsSSGT KHSRQSNNSH SPLPSN
>Q9NZJ5_GlobDoms
1-82, 143-565, 582-678, 866-1112
MERAISPGLL VRALLLLLLL LGLAARTVAA GRARGLPAPT AEAAFGLGAA AAPTSATRVP AAGAVAAAEV TVEDAEALPA AAgeqeprgp epddetelrp rgrslviist ldgriaaldp enhgkkqwdl dvgsgslvss slSKPEVFGN KMIIPSLDGA LFQWDQDRES METVPFTVES LLESSYKFGD DVVLVGGKSL TTYGLSAYSG KVRYICSALG CRQWDSDEME QEEDILLLQR TQKTVRAVGP RSGNEKWNFS VGHFELRYIP DMETRAGFIE STFKPNENTE ESKIISDVEE QEAAIMDIVI KVSVADWKVM AFSKKGGHLE WEYQFCTPIA SAWLLKDGKV IPISLFDDTS YTSNDDVLED EEDIVEAARG ATENSVYLGM YRGQLYLQSS VRISEKFPSS PKALESVTNE NAIIPLPTIK WKPLIHSPSR TPVLVGSDEF DKCLSNDKFS HEEYSNGALS ILQYPYDNGY YLPYYKRERN KRSTQITVRF LDNPHYNKNI RKKDPVLLLH WWKEIVATIL FCIIATTFIV RRLFHPHPHR QRKESETQCQ TENKYdsvsg eandsswndi kNSGYISRYL TDFEPIQCLG RGGFGVVFEA KNKVDDCNYA IKRIRLPNRE LAREKVMREV KALAKLEHPG IVRYFNAWLE APPEKWQEKM DEIWLKDEst dwplsspspm dapsvkirrm dpfatkehie iiapspqrsr sfsvgiscdq tsssesqfsp lefsgmdhed isesvdaayn lqdscltdcd vedgtmdgnd eghsfelcps easpyvrsre rtsssivfed sgcdnasske epktnrlhig nhcankltaf kptsskssse atlsispprp ttlslDLTKN TTEKLQPSSP KVYLYIQMQL CRKENLKDWM NGRCTIEERE RSVCLHIFLQ IAEAVEFLHS KGLMHRDLKP SNIFFTMDDV VKVGDFGLVT AMDQDEEEQT VLTPMPAYAR HTGQVGTKLY MSPEQIHGNS YSHKVDIFSL GLILFELLYP FSTQMERVRT LTDVRNLKFP PLFTQKYPCE YVMVQDMLSP SPMERPEAIN IIENAVFEDL DFPGKTVLRQ RSRSLSSSGT KHSRQSNNSH SPlpsn
JOB-ID: | Q9NZJ5_011209ZihcaX8AAAEAACDvQBIAAAAY |
---|---|
Paramters: | propensities=Russell/Linding smooth=10 dy/dx_smooth=10 |
Disorder frames: | peak-frame=5 join-frame=4 |
Globularity frames: | peak-frame=74 join-frame=15 |
Name: | Q9NZJ5 |
Description: | sp|Q9NZJ5|E2AK3_HUMAN Eukaryotic translation initiation factor 2-alpha kinase 3 OS=Homo sapiens OX=9606 GN=EIF2AK3 PE=1 SV=3 |
Plot title/ID: | none |
Sequence length: | 1116 |
Download Results | smoothed raw dydx |